# Mark C. Schneyer

Type: Person

Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/mark-c-schneyer
Canonical HTML page: https://getfinancebrief.com/entity/mark-c-schneyer

## Recent coverage (1 stories)

### Q4 Earnings Analysis: ACADIA and Alkami Navigate Growth and Market Volatility
2026-02-27 12:48:38 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

ACADIA Pharmaceuticals and Alkami Technology reported Q4 results that highlight divergent paths for mid-cap growth entities. While ACADIA focuses on the commercial scaling of its rare disease portfolio, Alkami is battling a significant stock correction despite beating revenue expectations.
Full story: https://getfinancebrief.com/story/acadia-alkami-q4-earnings-analysis-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.